Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Resources
Thought Leadership
Apr 24, 2025
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Scientific Publications
Apr 17, 2025
Large Language Models and Their Applications in Drug Discovery and Development: A Primer for Quantitative Clinical Pharmacology and Translational Sciences
Scientific Publications
Mar 8, 2025
Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences
Thought Leadership
Feb 24, 2025
From Empiric to Precise: Transforming Tacrolimus Dosing and Monitoring with MIPD
Scientific Publications
Jan 29, 2025
Improved Vancomycin Target Attainment Following a Quasi-Experimental Change in Pharmacokinetic Model for Bayesian Precision Dosing
Scientific Publications
Jan 10, 2025
Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosis
Thought Leadership
Dec 26, 2024
How are pharmacokinetic models selected for InsightRX Nova?
Thought Leadership
Dec 3, 2024
NCA vs. MAP Bayesian estimation for dose adjustment of busulfan and other medications
Thought Leadership
Nov 6, 2024
Heparin: the puppy who won’t sit still
1
2
3
4
5
